• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

公共推理与医疗保健优先事项设定:以英国国家卫生与临床优化研究所为例

Public Reasoning and Health-Care Priority Setting: The Case of NICE.

作者信息

Rumbold Benedict, Weale Albert, Rid Annette, Wilson James, Littlejohns Peter

出版信息

Kennedy Inst Ethics J. 2017;27(1):107-134. doi: 10.1353/ken.2017.0005.

DOI:10.1353/ken.2017.0005
PMID:28366905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6728154/
Abstract

Health systems that aim to secure universal patient access through a scheme of prepayments-whether through taxes, social insurance, or a combination of the two-need to make decisions on the scope of coverage that they guarantee: such tasks often falling to a priority-setting agency. This article analyzes the decision-making processes at one such agency in particular-the UK's National Institute for Health and Care Excellence (NICE)-and appraises their ethical justifiability. In particular, we consider the extent to which NICE's model can be justified on the basis of Rawls's conception of "reasonableness." This test shares certain features with the well-known Accountability for Reasonableness (AfR) model but also offers an alternative to it, being concerned with how far the values used by priority-setting agencies such as NICE meet substantive conditions of reasonableness irrespective of their procedural virtues. We find that while there are areas in which NICE's processes may be improved, NICE's overall approach to evaluating health technologies and setting priorities for health-care coverage is a reasonable one, making it an exemplar for other health-care systems facing similar coverage dilemmas. In so doing we offer both a framework for analysing the ethical justifiability of NICE's processes and one that might be used to evaluate others.

摘要

旨在通过预付费计划(无论是通过税收、社会保险还是两者结合)确保全民患者可及性的卫生系统,需要就其保障的覆盖范围做出决策:此类任务通常由一个确定优先事项的机构负责。本文特别分析了其中一个这样的机构——英国国家卫生与临床优化研究所(NICE)——的决策过程,并评估其伦理合理性。具体而言,我们考量NICE的模式在多大程度上能基于罗尔斯的“合理性”概念得到辩护。这个检验与著名的“合理性问责”(AfR)模式有某些共同特征,但也提供了一种替代方案,关注诸如NICE这样的确定优先事项机构所使用的价值观在多大程度上符合合理性的实质条件,而不论其程序优点如何。我们发现,虽然NICE的流程在某些方面可能有待改进,但NICE评估卫生技术和确定医疗保健覆盖优先事项的总体方法是合理的,使其成为面临类似覆盖困境的其他卫生保健系统的典范。在此过程中,我们既提供了一个分析NICE流程伦理合理性的框架,也提供了一个可用于评估其他流程的框架。

相似文献

1
Public Reasoning and Health-Care Priority Setting: The Case of NICE.公共推理与医疗保健优先事项设定:以英国国家卫生与临床优化研究所为例
Kennedy Inst Ethics J. 2017;27(1):107-134. doi: 10.1353/ken.2017.0005.
2
NICE and Fair? Health Technology Assessment Policy Under the UK's National Institute for Health and Care Excellence, 1999-2018.NICE 与公平?英国国家卫生与保健卓越研究所 1999-2018 年的卫生技术评估政策
Health Care Anal. 2020 Sep;28(3):193-227. doi: 10.1007/s10728-019-00381-x.
3
Justice, Transparency and the Guiding Principles of the UK's National Institute for Health and Care Excellence.公正、透明与英国国家卫生与临床优化研究所指导原则
Health Care Anal. 2022 Jun;30(2):115-145. doi: 10.1007/s10728-021-00444-y. Epub 2021 Nov 8.
4
Does NICE apply the rule of rescue in its approach to highly specialised technologies?NICE 在其对高度专业化技术的方法中是否适用救援规则?
J Med Ethics. 2022 Feb;48(2):118-125. doi: 10.1136/medethics-2020-106759. Epub 2021 Mar 8.
5
An empirical ethics study of the coherence of NICE technology appraisal policy and its implications for moral justification.一项关于 NICE 技术评估政策一致性及其对道德论证影响的经验伦理研究
BMC Med Ethics. 2024 Mar 6;25(1):28. doi: 10.1186/s12910-024-01016-0.
6
Exorcising the positivist ghost in the priority-setting machine: NICE and the demise of the 'social value judgement'.驱除优先级设定机制中的实证主义幽灵:英国国家卫生与临床优化研究所与“社会价值判断”的消亡
Health Econ Policy Law. 2021 Oct;16(4):505-511. doi: 10.1017/S1744133121000049. Epub 2021 Feb 11.
7
Innovation as a value in healthcare priority-setting: the UK experience.创新作为医疗保健优先事项设定中的一项价值:英国的经验。
Soc Justice Res. 2019;32(2):208-238. doi: 10.1007/s11211-019-00333-9. Epub 2019 Apr 15.
8
The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process.英国国家卫生与临床优化研究所(NICE)对成本效益的运用:并非(尚未成为)审慎程序的典范。
J Med Ethics. 2008 Jul;34(7):534-9. doi: 10.1136/jme.2007.021683.
9
Some inconsistencies in NICE's consideration of social values.英国国家卫生与临床优化研究所(NICE)在社会价值观考量方面存在一些不一致之处。
Pharmacoeconomics. 2014 Nov;32(11):1043-53. doi: 10.1007/s40273-014-0204-4.
10
The normative grounds for NICE decision-making: a narrative cross-disciplinary review of empirical studies.NICE 决策的规范基础:对经验研究的跨学科叙述性综述。
Health Econ Policy Law. 2022 Oct;17(4):444-470. doi: 10.1017/S1744133122000032. Epub 2022 Mar 16.

引用本文的文献

1
Procedural fairness and the resilience of health financing reforms in Ukraine.程序公平与乌克兰卫生筹资改革的韧性
Health Policy Plan. 2023 Nov 14;38(Supplement_1):i59-i72. doi: 10.1093/heapol/czad062.
2
Criteria for the procedural fairness of health financing decisions: a scoping review.卫生筹资决策程序公正性标准:范围综述。
Health Policy Plan. 2023 Nov 14;38(Supplement_1):i13-i35. doi: 10.1093/heapol/czad066.
3
Cost-effectiveness of incorporating Ebola prediction score tools and rapid diagnostic tests into a screening algorithm: A decision analytic model.将埃博拉预测评分工具和快速诊断测试纳入筛查算法的成本效益:决策分析模型。
PLoS One. 2023 Oct 17;18(10):e0293077. doi: 10.1371/journal.pone.0293077. eCollection 2023.
4
Evidence-Informed Deliberative Processes for UHC: Progress, Potential and Prudence Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".基于循证的全民医保决策过程:进展、潜力与审慎——评“基于循证的卫生福利包设计决策过程:第二部分:实用指南”
Int J Health Policy Manag. 2023;12:7541. doi: 10.34172/ijhpm.2022.7541. Epub 2023 Feb 13.
5
Can Voluntary Health Insurance for Non-reimbursed Expensive New Treatments Be Just?非报销性昂贵新疗法的自愿健康保险能否做到公平?
Public Health Ethics. 2023 Jul 16;16(2):191-201. doi: 10.1093/phe/phad015. eCollection 2023 Jul.
6
Moral expertise without moral elitism.非道德精英主义的道德专长。
Bioethics. 2023 Jul;37(6):564-574. doi: 10.1111/bioe.13034. Epub 2022 Apr 11.
7
Justice, Transparency and the Guiding Principles of the UK's National Institute for Health and Care Excellence.公正、透明与英国国家卫生与临床优化研究所指导原则
Health Care Anal. 2022 Jun;30(2):115-145. doi: 10.1007/s10728-021-00444-y. Epub 2021 Nov 8.
8
Maximising benefit, reducing inequalities and ensuring deliverability: Prioritisation of COVID-19 vaccination in the UK.利益最大化、减少不平等并确保可交付性:英国新冠疫苗接种的优先排序
Lancet Reg Health Eur. 2021 Mar;2:100021. doi: 10.1016/j.lanepe.2020.100021. Epub 2020 Dec 23.
9
The Value of Data: Applying a Public Value Model to the English National Health Service.数据的价值:将公共价值模型应用于英国国家医疗服务体系。
J Med Internet Res. 2020 Mar 27;22(3):e15816. doi: 10.2196/15816.
10
Affordability and Non-Perfectionism in Moral Action.道德行为中的可承受性与非完美主义。
Ethical Theory Moral Pract. 2019;22(4):973-991. doi: 10.1007/s10677-019-10028-4. Epub 2019 Sep 14.

本文引用的文献

1
Value congruence in health care priority setting: social values, institutions and decisions in three countries.医疗保健优先级设定中的价值一致性:三个国家的社会价值观、制度与决策
Health Econ Policy Law. 2015 Apr;10(2):113-32. doi: 10.1017/S1744133114000437. Epub 2014 Dec 1.
2
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.美国心脏病学会/美国心脏协会关于临床实践指南和绩效指标中成本/价值方法的声明:美国心脏病学会/美国心脏协会绩效指标特别工作组和实践指南特别工作组的报告
Circulation. 2014 Jun 3;129(22):2329-45. doi: 10.1161/CIR.0000000000000042. Epub 2014 Mar 27.
3
Social values and health priority setting in England: "values" based decision making.英格兰的社会价值观和卫生重点制定:基于“价值观”的决策。
J Health Organ Manag. 2012;26(3):363-73. doi: 10.1108/14777261211239007.
4
Is the aim of the English health care system to maximize QALYs?英国的医疗保健系统的目标是使 QALYs 最大化吗?
J Health Serv Res Policy. 2012 Jul;17(3):157-63. doi: 10.1258/JHSRP.2012.011098. Epub 2012 Jul 5.
5
Pharmacoeconomics: NICE's approach to decision-making.药物经济学:英国国家卫生与临床优化研究所的决策方法。
Br J Clin Pharmacol. 2010 Sep;70(3):346-9. doi: 10.1111/j.1365-2125.2009.03589.x.
6
Is the United States ready for QALYs?美国是否准备好使用 QALYs 了?
Health Aff (Millwood). 2009 Sep-Oct;28(5):1366-71. doi: 10.1377/hlthaff.28.5.1366.
7
Justice and procedure: how does "accountability for reasonableness" result in fair limit-setting decisions?正义与程序:“合理性问责制”如何带来公平的限制设定决策?
J Med Ethics. 2009 Jan;35(1):12-6. doi: 10.1136/jme.2008.024430.
8
NICE's use of cost effectiveness as an exemplar of a deliberative process.国家卫生与临床优化研究所将成本效益用作审议过程的一个范例。
Health Econ Policy Law. 2006 Jul;1(Pt 3):299-318. doi: 10.1017/S1744133106004026.
9
The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process.英国国家卫生与临床优化研究所(NICE)对成本效益的运用:并非(尚未成为)审慎程序的典范。
J Med Ethics. 2008 Jul;34(7):534-9. doi: 10.1136/jme.2007.021683.
10
Rights, responsibilities and NICE: a rejoinder to Harris.权利、责任与英国国家卫生与临床优化研究所:对哈里斯的回应
J Med Ethics. 2007 Aug;33(8):462-4. doi: 10.1136/jme.2006.018903.